Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,825 | -4,843 | -3,171 | -1,678 | -5,813 |
| Depreciation Amortization | 8 | 6 | 5 | 3 | 5 |
| Other Working Capital | 352 | 790 | 557 | 327 | 573 |
| Other Operating Activity | -2,434 | -1,566 | -557 | 9 | -330 |
| Operating Cash Flow | $-7,899 | $-5,613 | $-3,166 | $-1,338 | $-5,565 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -4 |
| Other Investing Activity | -109 | 0 | 0 | 0 | 463 |
| Investing Cash Flow | $-109 | $N/A | $N/A | $N/A | $459 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 366 | 34 | 34 | 32 | N/A |
| Other Financing Activity | 0 | -125 | 0 | 0 | 11,721 |
| Financing Cash Flow | $366 | $-91 | $34 | $32 | $11,721 |
| Exchange Rate Effect | -238 | -307 | -461 | -186 | 12 |
| Beginning Cash Position | 10,953 | 11,047 | 11,201 | 10,440 | 4,067 |
| End Cash Position | 3,073 | 5,035 | 7,608 | 8,948 | 10,694 |
| Net Cash Flow | $-7,880 | $-6,012 | $-3,593 | $-1,492 | $6,627 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,899 | -5,613 | -3,166 | -1,338 | -5,565 |
| Free Cash Flow | -7,899 | -5,613 | -3,166 | -1,338 | -5,565 |